LIVIVO - Search results -

Search results

Result 1 - 10 of total 24

Search options

Article ; Online: Respiratorische Allergien bei Kindern und Jugendlichen--Stellenwert der Komponentendiagnostik und spezifischen Immuntherapie.

Horak, Fritz

Wiener medizinische Wochenschrift (1946)

2015 Volume 165, Issue 17-18, Page(s) 347–353

Abstract: Respiratory allergies of children and adolescents are an important issue in allergology. In parallel to increasing prevalence rates also research has rapidly been developing for the last 10 years. Today we can better understand complex systems to improve ...

Title translation	Respiratory allergies in children and adolescents: the role of component-resolved diagnosis and specific immunotherapy.
Abstract	Respiratory allergies of children and adolescents are an important issue in allergology. In parallel to increasing prevalence rates also research has rapidly been developing for the last 10 years. Today we can better understand complex systems to improve our diagnostic and therapeutic accuracy. In addition to medical history, skin-prick-testing and analysis of specific IgE to allergen extracts, component resolved diagnosis has gained importance in the last years. While being increasingly helpful in the diagnosis of insect-venom and food-allergies, component-based diagnosis can also improve the management of patients with respiratory allergies. Concerning different therapeutic approaches like allergen-avoidance or symptomatic therapy, specific immunotherapy (SIT) is one of the most interesting therapy-options, as it is still the only causal therapy available. After reasonable patient-selection and the selection of the right allergen and product, SIT has a very good risk/benefit-ration and can induce long-term immuno-tolerance to specific allergens.
MeSH term(s)	Adolescent ; Allergens/immunology ; Child ; Desensitization, Immunologic/methods ; Epitopes/immunology ; Humans ; Immunoglobulin E/blood ; Intradermal Tests ; Recurrence ; Respiratory Hypersensitivity/etiology ; Respiratory Hypersensitivity/immunology ; Respiratory Hypersensitivity/therapy
Chemical Substances	Allergens ; Epitopes ; Immunoglobulin E (37341-29-0)
Language	German
Publishing date	2015-09
Publishing country	Austria
Document type	English Abstract ; Journal Article ; Review
ZDB-ID	123613-1
ISSN	1563-258X ; 0254-7945 ; 0043-5341
ISSN (online)	1563-258X
ISSN	0254-7945 ; 0043-5341
DOI	10.1007/s10354-015-0375-4
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 903: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾

Article: T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy.

Reithofer, Manuel / Boell, Simone Lisa / Kitzmueller, Claudia / Horak, Fritz / Bohle, Barbara / Jahn-Schmid, Beatrice

Heliyon

2023 Volume 9, Issue 11, Page(s) e21878

Abstract: Allergen-specific immunotherapy (AIT) is the only treatment for type I allergy, which achieves long-lasting effects. Repeated subcutaneous applications of allergen extracts cause a protective antibody response and an immune deviation of T cells. In AIT ... ...

Abstract	Allergen-specific immunotherapy (AIT) is the only treatment for type I allergy, which achieves long-lasting effects. Repeated subcutaneous applications of allergen extracts cause a protective antibody response and an immune deviation of T cells. In AIT with allergoids, chemically modified allergen extracts are injected. During a so-called special pre-seasonal application scheme, after the initial phase of applying increased doses of allergoids is followed by natural allergen exposure as a maintenance phase. The effectiveness of allergoid vaccines has been described regarding the improvement of clinical symptoms and the development of protective humoral responses. In this longitudinal observational study, we sought to investigate changes at the T cell level in pre-seasonal AIT with allergoid. Different subsets within CD4
Language	English
Publishing date	2023-11-10
Publishing country	England
Document type	Journal Article
ZDB-ID	2835763-2
ISSN	2405-8440
ISSN	2405-8440
DOI	10.1016/j.heliyon.2023.e21878
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: FDA warning montelukast 03.2020-Statement of the Austrian working group of pediatric pulmonology and allergology.

Zschocke, Anna / Horak, Fritz / Eber, Ernst / Frischer, Thomas / Simma, Burkhardt / Stetzl, Wolfgang / Riedler, Josef / Szépfalusi, Zsolt / Zacharasiewicz, Angela

Wiener klinische Wochenschrift

2021 Volume 134, Issue 1-2, Page(s) 86–88

Abstract: Montelukast, a leukotriene receptor antagonist (LTRA) has been approved for use in Europe since 1998. Indications for use (from the age of 6 months) include mild to moderate asthma, seasonal allergic rhinitis with asthma, and the prevention of exercise- ... ...

Abstract	Montelukast, a leukotriene receptor antagonist (LTRA) has been approved for use in Europe since 1998. Indications for use (from the age of 6 months) include mild to moderate asthma, seasonal allergic rhinitis with asthma, and the prevention of exercise-induced asthma episodes. The psychiatric side effects of montelukast have been known for the last 10 years; in the case of such symptoms benefits and risks should be considered. Due to potential life-threatening psychiatric adverse events, particularly suicide, a black box warning was issued. In this statement the Austrian working group of pediatric pulmonology and allergology advises that treatment with montelukast should be started only after critical evaluation. Treatment should be stopped on the occurrence of any neuropsychiatric side effects.
MeSH term(s)	Acetates/adverse effects ; Anti-Asthmatic Agents/adverse effects ; Austria ; Child ; Cyclopropanes ; Humans ; Infant ; Pulmonary Medicine ; Quinolines/adverse effects ; Sulfides
Chemical Substances	Acetates ; Anti-Asthmatic Agents ; Cyclopropanes ; Quinolines ; Sulfides ; montelukast (MHM278SD3E)
Language	English
Publishing date	2021-12-13
Publishing country	Austria
Document type	Journal Article
ZDB-ID	200462-8
ISSN	1613-7671 ; 0043-5325 ; 0300-5178
ISSN (online)	1613-7671
ISSN	0043-5325 ; 0300-5178
DOI	10.1007/s00508-021-01981-1
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 902: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines.

Altrichter, Sabine / Wöhrl, Stefan / Horak, Fritz / Idzko, Marco / Jordakieva, Galateja / Untersmayr, Eva / Szepfalusi, Zsolt / Zieglmayer, Petra / Jensen-Jarolim, Erika / Wiedermann, Ursula / Rosenkranz, Alexander / Hötzenecker, Wolfram

Allergo journal international

2021 Volume 30, Issue 5, Page(s) 169–175

Abstract: Background: Along with the newly approved vaccines against coronavirus disease 2019 (COVID-19), first reports of allergic or intolerance reactions were published. Subsequently, questions arose whether these vaccines pose an increased risk for ... ...

Abstract	Background: Along with the newly approved vaccines against coronavirus disease 2019 (COVID-19), first reports of allergic or intolerance reactions were published. Subsequently, questions arose whether these vaccines pose an increased risk for intolerance reactions and whether allergic patients may be at higher risk for this. Results: Allergic reactions following COVID-19 vaccinations have been reported, but mostly of mild severity and at normal (Moderna®) or only slightly increased frequency (BioNTech/Pfizer®) compared to established conventional vaccines. The risk of allergic reaction to the newly licensed vector vaccines (AstraZeneca®, Johnson&Johnson®) cannot be conclusively assessed yet, but also appears to be low. There is currently no evidence that patients with allergic diseases (atopic patients) react more frequently or more severely to these vaccines. It is currently assumed that intolerance reactions of the immediate-type are either type I allergic (IgE-mediated) reactions or occur via complement activation (CARPA, "complement activation-related pseudoallergy"). Polyethylene glycol (PEG) or polysorbate, which are present as stabilizers in the vaccines, are suspected as triggers for this. Conclusion: The data available so far do not show a significantly increased risk of immediate-type allergic reactions in atopic persons. In almost all cases, atopic patients can be vaccinated without problems. Standardized follow-up tests after suspected allergic reactions or CARPA-mediated reactions are currently limited.
Language	English
Publishing date	2021-07-14
Publishing country	Germany
Document type	Journal Article ; Review
ISSN	2197-0378
ISSN	2197-0378
DOI	10.1007/s40629-021-00177-3
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

Article ; Online: IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1.

Grilo, João Rodrigues / Kitzmüller, Claudia / Aglas, Lorenz / Sánchez Acosta, Gabriela / Vollmann, Ute / Ebner, Christof / Horak, Fritz / Kinaciyan, Tamar / Radauer, Christian / Ferreira, Fatima / Jahn-Schmid, Beatrice / Bohle, Barbara

Allergy

2021 Volume 76, Issue 8, Page(s) 2555–2564

Abstract: Background: Evidence has accumulated that birch pollen immunotherapy reduces rhinoconjunctivitis to pollen of birch homologous trees. Therapeutic efficacy has been associated with IgE-blocking IgG antibodies. We have recently shown that sera collected ... ...

Abstract	Background: Evidence has accumulated that birch pollen immunotherapy reduces rhinoconjunctivitis to pollen of birch homologous trees. Therapeutic efficacy has been associated with IgE-blocking IgG antibodies. We have recently shown that sera collected after 16 weeks of sublingual immunotherapy with recombinant Bet v 1 (rBet v 1-SLIT) display strong IgE-blocking bioactivity for Bet v 1. Here, we assessed whether rBet v 1-SLIT-induced IgG antibodies display cross-blocking activity to related allergens in Fagales pollen. Methods: IgE, IgG1 and IgG4 reactivity to recombinant Bet v 1, Aln g 1, Car b 1, Ost c 1, Cor a 1, Fag s 1, Cas s 1 and Que a 1 were assessed in pre- and post-SLIT samples of 17 individuals by ELISA. A basophil inhibition assay using stripped basophils re-sensitized with a serum pool containing high Bet v 1-specific IgE levels was established and used to assess CD63 expression in response to allergens after incubation with pre-SLIT or post-SLIT samples. IgG1 and IgG4 were depleted from post-SLIT samples to assess its contribution to IgE-cross-blocking. Results: Sublingual immunotherapy with recombinant Bet v 1 boosted cross-reactive IgE antibodies and induced IgG1 and IgG4 antibodies with inter- and intra-individually differing reactivity to the homologs. Highly variable cross-blocking activities of post-SLIT samples to the different allergens were found. IgG1 and IgG4 antibodies displayed cross-blocking activity with individual variance. Conclusions: Our mechanistic approach suggested that immunotherapy with the reference allergen Bet v 1 induces individual repertoires of cross-reactive IgG1 and IgG4 antibodies. The cross-blocking bioactivity of these antibodies was also highly variable and neither predictable from protein homology nor IgE-cross-reactivity.
MeSH term(s)	Allergens ; Antibodies, Blocking ; Antigens, Plant/immunology ; Antigens, Plant/therapeutic use ; Fagales ; Humans ; Immunoglobulin E ; Plant Proteins ; Recombinant Proteins ; Sublingual Immunotherapy
Chemical Substances	Allergens ; Antibodies, Blocking ; Antigens, Plant ; Plant Proteins ; Recombinant Proteins ; Bet v 1 allergen, Betula (126161-14-6) ; Immunoglobulin E (37341-29-0)
Language	English
Publishing date	2021-05-06
Publishing country	Denmark
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	391933-x
ISSN	1398-9995 ; 0105-4538
ISSN (online)	1398-9995
ISSN	0105-4538
DOI	10.1111/all.14817
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Uh III Zs.150: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 125: Show issues

Order via subito

Details ▾

Article ; Online: Therapie mit inhalativen Glukokortikoiden bei COVID-19.

Idzko, Marco / Lommatzsch, Marek / Taube, Christian / Eber, Ernst / Lamprecht, Bernd / Horak, Fritz / Pohl, Wolfgang / Rabe, Klaus F / Virchow, Johann Christian / Hamelmann, Eckard / Pfeifer, Michael / Bauer, Torsten / Buhl, Roland

Pneumologie (Stuttgart, Germany)

2021 Volume 75, Issue 6, Page(s) 418–420

Title translation	Treatment of COVID-19 with Inhaled Glucocorticoids - Statement of the German Respiratory Society (DGP), the Austrian Society of Pneumology (ÖGP) and the German Society of Allergology and Clinical Immunology (DGAKI).
MeSH term(s)	Austria ; Budesonide ; COVID-19 ; Glucocorticoids ; Humans ; Pulmonary Medicine ; SARS-CoV-2
Chemical Substances	Glucocorticoids ; Budesonide (51333-22-3)
Language	German
Publishing date	2021-05-17
Publishing country	Germany
Document type	Journal Article ; Comment
ZDB-ID	607630-0
ISSN	1438-8790 ; 0934-8387
ISSN (online)	1438-8790
ISSN	0934-8387
DOI	10.1055/a-1488-5373
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uh II Zs.142: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 54: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: [No title information]

Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung

2021 Volume 30, Issue 5, Page(s) 48–54

Title translation	Antworten auf brennende Fragen an klinische Allergolog*innen im Zusammenhang mit den neuen COVID-19-Impfstoffen.
Language	German
Publishing date	2021-08-13
Publishing country	Germany
Document type	Journal Article ; Review
ZDB-ID	1136943-7
ISSN	0941-8849
ISSN	0941-8849
DOI	10.1007/s15007-021-4847-0
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 3566: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Erratum: S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023.

Lommatzsch, Marek / Criée, Carl-Peter / de Jong, Carmen C M / Gappa, Monika / Geßner, Christian / Gerstlauer, Michael / Hämäläinen, Nina / Haidl, Peter / Hamelmann, Eckard / Horak, Fritz / Idzko, Marco / Ignatov, Atanas / Koczulla, Andreas Rembert / Korn, Stephanie / Köhler, Michael / Lex, Christiane / Meister, Jochen / Milger-Kneidinger, Katrin / Nowak, Dennis /

Pneumologie (Stuttgart, Germany)

2024 Volume 77, Issue 8, Page(s) e3

Title translation	Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.
Language	German
Publishing date	2024-03-21
Publishing country	Germany
Document type	Journal Article ; Published Erratum
ZDB-ID	607630-0
ISSN	1438-8790 ; 0934-8387
ISSN (online)	1438-8790
ISSN	0934-8387
DOI	10.1055/a-2284-8593
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uh II Zs.142: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 54: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Therapie mit inhalativen Glukokortikoiden bei COVID-19

Idzko, Marco / Lommatzsch, Marek / Taube, Christian / Eber, Ernst / Lamprecht, Bernd / Horak, Fritz / Pohl, Wolfgang / Rabe, Klaus F. / Virchow, Johann Christian / Hamelmann, Eckard / Pfeifer, Michael / Bauer, Torsten / Buhl, Roland

Pneumologie

2021 Volume 75, Issue 06, Page(s) 418–420

Language	German
Publishing date	2021-05-17
Publisher	Georg Thieme Verlag KG
Publishing place	Stuttgart ; New York
Document type	Article
ZDB-ID	607630-0
ISSN	1438-8790 ; 0934-8387
ISSN (online)	1438-8790
ISSN	0934-8387
DOI	10.1055/a-1488-5373
Database	Thieme publisher's database

In stock of ZB MED Cologne/Königswinter

Uh II Zs.142: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 54: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines.

Horak, Fritz / Doberer, Daniel / Eber, Ernst / Horak, Elisabeth / Pohl, Wolfgang / Riedler, Josef / Szépfalusi, Zsolt / Wantke, Felix / Zacharasiewicz, Angela / Studnicka, Michael

Wiener klinische Wochenschrift

2016 Volume 128, Issue 15-16, Page(s) 541–554

Abstract: This statement was written by a group of pulmonologists and pediatric pulmonologists belonging to the corresponding professional associations ÖGP (Austrian Society for Pulmonology) and ÖGKJ (Austrian Society for pediatric and adolescent medicine) to ... ...

Abstract	This statement was written by a group of pulmonologists and pediatric pulmonologists belonging to the corresponding professional associations ÖGP (Austrian Society for Pulmonology) and ÖGKJ (Austrian Society for pediatric and adolescent medicine) to provide a concise overview of the latest updates in the 2015 GINA Guidelines and to include aspects that are specific to Austria.
MeSH term(s)	Anti-Asthmatic Agents/administration & dosage ; Asthma/diagnosis ; Asthma/therapy ; Austria ; Child, Preschool ; Combined Modality Therapy/standards ; Drug Monitoring/standards ; Evidence-Based Medicine/standards ; Female ; Humans ; Immunotherapy/standards ; Infant ; Infant, Newborn ; Male ; Medical History Taking/standards ; Pediatrics/standards ; Practice Guidelines as Topic ; Pulmonary Medicine/standards ; Respiratory Function Tests/standards
Chemical Substances	Anti-Asthmatic Agents
Language	English
Publishing date	2016-08
Publishing country	Austria
Document type	Journal Article
ZDB-ID	200462-8
ISSN	1613-7671 ; 0043-5325 ; 0300-5178
ISSN (online)	1613-7671
ISSN	0043-5325 ; 0300-5178
DOI	10.1007/s00508-016-1019-4
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 902: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito